Clinical Trials Logo

Clinical Trial Details — Status: Terminated

Administrative data

NCT number NCT01903642
Other study ID # Bonnotte PHRC IR 2008
Secondary ID
Status Terminated
Phase N/A
First received July 17, 2013
Last updated July 17, 2013
Start date March 2010
Est. completion date February 2012

Study information

Verified date July 2013
Source Centre Hospitalier Universitaire Dijon
Contact n/a
Is FDA regulated No
Health authority France: Afssaps - Agence française de sécurité sanitaire des produits de santé (Saint-Denis)
Study type Interventional

Clinical Trial Summary

The hypotheses of our research are based on the fact that various pathological states, infection, cancer, inflammatory disease, can induce an inflammatory syndrome, through different pathways, even though the clinical presentation can be identical. The identification of biological markers specific to an etiology would therefore allow a faster diagnosis and improve care for patients. We thus took an interest in the three groups of diseases most frequently responsible for an inflammatory syndrome, infections, cancers and auto-immune diseases. To achieve this, various methods will be used.


Recruitment information / eligibility

Status Terminated
Enrollment 97
Est. completion date February 2012
Est. primary completion date January 2011
Accepts healthy volunteers No
Gender Both
Age group 18 Years to 90 Years
Eligibility Inclusion Criteria:

Patients presenting an inflammatory syndrome, defined by elevated C-reactive protein (CRP>50mg/L), whose etiology is related to infection, cancer or an inflammatory disease.

- Patients not on treatment (corticoids, immunosuppressive drugs) during the 7 days preceding inclusion

- Age: 18-90 years

- Patients covered by the National Health Insurance Agency

- signed written informed consent form

Exclusion Criteria:

- - Any patient not meeting the inclusion criteria

- Pregnant patients

Study Design

Allocation: Randomized, Intervention Model: Single Group Assignment, Masking: Open Label


Related Conditions & MeSH terms


Intervention

Other:
proteomic analysis


Locations

Country Name City State
France CHU de Dijon Dijon

Sponsors (1)

Lead Sponsor Collaborator
Centre Hospitalier Universitaire Dijon

Country where clinical trial is conducted

France, 

Outcome

Type Measure Description Time frame Safety issue
Primary determination of usual parameters of inflammation at baseline No
See also
  Status Clinical Trial Phase
Completed NCT03964324 - NO Measurements in Screening for Asthma and OSA, in Patients With Severe Snoring N/A
Recruiting NCT03963648 - NO Measurements in Screening for Asthma and OSA, in Patients With CRSwNP N/A
Not yet recruiting NCT04997343 - Neurophysiological Assessment in Patients With Multiple Sclerosis N/A
Completed NCT01695876 - A Phase I Study to Evaluate the Safety, Tolerability, Pharmacokinetics (PK), Pharmacodynamics (PD), Food Effect of AMG 357 in Healthy Subjects Phase 1
Not yet recruiting NCT05546788 - Hydroxylated Polymethoxy Flavones Solid Dispersion in Treatment of Periodontitis Phase 1
Recruiting NCT03651518 - Personalized Therapies in Inflammatory Complex Disease Phase 2
Not yet recruiting NCT05544448 - In Vitro Effect Study of Interleukin-2 Muteins on Regulatory T Cells of Patients With Different Autoimmune, Allo-immune or Inflammatory Diseases N/A
Completed NCT02552004 - Assessment of Intraoperative Probe-based Confocal Laser Endomicroscopy in Digestive and Endocrine Surgery: a Pilot Study N/A
Completed NCT04368494 - Exercise Therapy in Patients With Axial Spondyloarthritis N/A
Completed NCT03878134 - Translational Development of Photon-counting CT Imaging N/A
Recruiting NCT06059989 - inDuctIon tREatment With subCuTaneous Infliximab for Crohn's Disease Phase 3
Completed NCT02959138 - Pharmacokinetics of Lanraplenib in Adults With Impaired Renal Function Phase 1
Active, not recruiting NCT04565821 - Feasibility Study to Assess a Trans-nasal Intestinal Potential Difference Probe N/A
Recruiting NCT05509075 - Nutraceuticals and Functional Foods
Active, not recruiting NCT06448052 - Umbilical Cord Mesenchymal Stem Cell for Aging-related Low-grade Inflammation Phase 1/Phase 2
Active, not recruiting NCT05944822 - Pro-inflammatory Cytokines in Case of Essure®
Completed NCT05115370 - Vaccination Perception in Inflammatory Conditions - Flu, Pneumonia and COVID-19
Active, not recruiting NCT03604406 - The Immunogenicity and Safety of Zostavax® and Shingrix® in Rheumatoid Arthritis Patients Using Abatacept Phase 2
Completed NCT05022017 - Description of Statics by EOS Imaging and Evaluation of the Efficacy of Intradiscal Corticosteroid Infiltration
Recruiting NCT05364294 - Molecular Diagnosis of Systemic Autoinflammatory Diseases